These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9924695)
1. Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR). Coral S; Sigalotti L; Gasparollo A; Cattarossi I; Visintin A; Cattelan A; Altomonte M; Maio M J Immunother; 1999 Jan; 22(1):16-24. PubMed ID: 9924695 [TBL] [Abstract][Full Text] [Related]
2. Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications. Fonsatti E; Nicolay HJ; Sigalotti L; Calabrò L; Pezzani L; Colizzi F; Altomonte M; Guidoboni M; Marincola FM; Maio M Clin Cancer Res; 2007 Jun; 13(11):3333-8. PubMed ID: 17545540 [TBL] [Abstract][Full Text] [Related]
3. 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications. Coral S; Sigalotti L; Altomonte M; Engelsberg A; Colizzi F; Cattarossi I; Maraskovsky E; Jager E; Seliger B; Maio M Clin Cancer Res; 2002 Aug; 8(8):2690-5. PubMed ID: 12171902 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications. Coral S; Sigalotti L; Colizzi F; Spessotto A; Nardi G; Cortini E; Pezzani L; Fratta E; Fonsatti E; Di Giacomo AM; Nicotra MR; Natali PG; Altomonte M; Maio M J Cell Physiol; 2006 Apr; 207(1):58-66. PubMed ID: 16252259 [TBL] [Abstract][Full Text] [Related]
5. The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma. Natsume A; Wakabayashi T; Tsujimura K; Shimato S; Ito M; Kuzushima K; Kondo Y; Sekido Y; Kawatsura H; Narita Y; Yoshida J Int J Cancer; 2008 Jun; 122(11):2542-53. PubMed ID: 18240144 [TBL] [Abstract][Full Text] [Related]
6. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine. Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288 [TBL] [Abstract][Full Text] [Related]
7. Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules. Adair SJ; Hogan KT Cancer Immunol Immunother; 2009 Apr; 58(4):589-601. PubMed ID: 18791715 [TBL] [Abstract][Full Text] [Related]
8. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine. Karpf AR; Lasek AW; Ririe TO; Hanks AN; Grossman D; Jones DA Mol Pharmacol; 2004 Jan; 65(1):18-27. PubMed ID: 14722233 [TBL] [Abstract][Full Text] [Related]
9. Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment. Serrano A; Tanzarella S; Lionello I; Mendez R; Traversari C; Ruiz-Cabello F; Garrido F Int J Cancer; 2001 Oct; 94(2):243-51. PubMed ID: 11668505 [TBL] [Abstract][Full Text] [Related]
10. Effect of 5-aza-2'-deoxycytidine on immune-associated proteins in exosomes from hepatoma. Xiao WH; Sanren GW; Zhu JH; Li QW; Kang HR; Wang RL; Song LP; Ye M World J Gastroenterol; 2010 May; 16(19):2371-7. PubMed ID: 20480522 [TBL] [Abstract][Full Text] [Related]
11. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051 [TBL] [Abstract][Full Text] [Related]
12. Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1. Krishnadas DK; Bao L; Bai F; Chencheri SC; Lucas K Tumour Biol; 2014 Jun; 35(6):5753-62. PubMed ID: 24584817 [TBL] [Abstract][Full Text] [Related]
13. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient. Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316 [TBL] [Abstract][Full Text] [Related]
15. Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma. Sigalotti L; Coral S; Nardi G; Spessotto A; Cortini E; Cattarossi I; Colizzi F; Altomonte M; Maio M J Immunother; 2002; 25(1):16-26. PubMed ID: 11924907 [TBL] [Abstract][Full Text] [Related]
16. [Effects of 5-aza-2'-deoxycytidine on the amount of exosomes and secreted immuno-associated proteins by hepatoma cells]. Sanrengaowa ; Wu Y; Xiao WH Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):495-9. PubMed ID: 19950695 [TBL] [Abstract][Full Text] [Related]
17. MAGED4 expression in glioma and upregulation in glioma cell lines with 5-aza-2'-deoxycytidine treatment. Zhang QM; Shen N; Xie S; Bi SQ; Luo B; Lin YD; Fu J; Zhou SF; Luo GR; Xie XX; Xiao SW Asian Pac J Cancer Prev; 2014; 15(8):3495-501. PubMed ID: 24870746 [TBL] [Abstract][Full Text] [Related]
18. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. Geertsen RC; Hofbauer GF; Yue FY; Manolio S; Burg G; Dummer R J Invest Dermatol; 1998 Sep; 111(3):497-502. PubMed ID: 9740247 [TBL] [Abstract][Full Text] [Related]
19. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines. Poláková K; Bandzuchová E; Kuba D; Russ G Leuk Res; 2009 Apr; 33(4):518-24. PubMed ID: 18823661 [TBL] [Abstract][Full Text] [Related]
20. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Wischnewski F; Pantel K; Schwarzenbach H Mol Cancer Res; 2006 May; 4(5):339-49. PubMed ID: 16687489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]